Administering emulsion drops in dry eye patients improves tear stability and decreases osmolarity and corneal staining.
Administering emulsion drops in dry eye patients improves tear stability and decreases osmolarity and corneal staining, revealed a study in Cornea.
The investigation, led by Dr Louise McCann, Department of Vision Sciences, Glasgow Caledonian University, UK, included 75 dry eye patients who were randomized into 3 groups. Each subject received either sodium hyaluronate, hydroxypropyl methylcellulose (HPMC) or emulsion drops four times daily for 90 days. At days 7 and 60 a compliance visit was conducted.
In all groups a significant improvement in evaporation and all symptoms was recorded. However, there were no significant findings in tear turnover rate (TTR) for any of the three solutions.
In the emulsion and sodium hyaluronate group there was a significant difference in tear stability and non-invasive tear break-up time. The emulsion group demonstrated a significant decrease in osmolarity and corneal staining.
All therapy groups presented with a significant reduction in evaporation, although there was no significant changes in TTR demonstrated in any of the groups. The results suggest that long-term use of emulsion drops demonstrates consistency with lipid layer tear film improvements.
AAO 2024: Transient vision loss with Alexander Fein, MD
October 21st 2024Alexander Fein, MD, spoke with the Eye Care Network to share how to approach a patient presenting with transient vision loss, what this type of vision loss can mean, and what additional testing might be needed to determine the best plan for care.
AAO 2024: Optimal pupil size reduction percentage for near vision improvement in presbyopia
October 21st 2024Jennifer Loh, MD, shared insights from on her presentation at the American Academy of Ophthalmology meeting in Chicago on the effects of CSF-1, which is the lowest effective concentration of pilocarpine approved in the United States.